Related Experiment Videos
CSF somatostatin in childhood psychiatric disorders: a preliminary investigation
M J Kruesi1, S Swedo, H Leonard
1Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892.
Insights
Pediatric disruptive behavior disorders show lower somatostatin levels in cerebrospinal fluid (CSF) compared to obsessive-compulsive disorder. This finding suggests a potential neurochemical difference in these conditions.
Area of Science:
- Neuroscience
- Pediatric Psychiatry
- Endocrinology
Background:
- Disruptive behavior disorders (DBD) and obsessive-compulsive disorder (OCD) are linked to serotonergic system dysfunction in children.
- Previous research suggests potential associations between these disorders and specific physical characteristics.
- Somatostatin, a peptide influencing serotonin and growth hormone, has been implicated in various neurological and psychiatric conditions.
Purpose of the Study:
- To investigate cerebrospinal fluid (CSF) somatostatin concentrations in pediatric patients diagnosed with disruptive behavior disorders.
- To compare CSF somatostatin levels between children with disruptive behavior disorders and age-, sex-, and race-matched children with obsessive-compulsive disorder.
- To explore the relationship between somatostatin levels, Tanner stage, and depressive state in pediatric patients.
Main Methods:
- Cerebrospinal fluid (CSF) samples were collected from 10 pediatric patients with disruptive behavior disorders.
- CSF samples were also collected from 10 age-, sex-, and race-matched pediatric patients with obsessive-compulsive disorder.
- Somatostatin concentrations in CSF were measured and compared between the two groups, controlling for Tanner stage.
Main Results:
- Children with disruptive behavior disorders exhibited significantly decreased concentrations of somatostatin in their CSF compared to children with obsessive-compulsive disorder.
- This difference remained significant even after accounting for variations in Tanner stage.
- Unlike findings in adult studies, a depressed state in these pediatric patients was not associated with lower CSF somatostatin levels.
Conclusions:
- Reduced cerebrospinal fluid somatostatin may represent a distinct neurobiological marker differentiating pediatric disruptive behavior disorders from obsessive-compulsive disorder.
- These findings highlight potential differences in serotonergic pathways and neuroendocrine regulation between these pediatric conditions.
- Further research is warranted to elucidate the functional implications of these somatostatin level differences in pediatric DBD and OCD.
Abstract:
Disruptive behavior disorders and obsessive-compulsive disorder have been associated with serotonergic dysfunction as well as particular body habitus findings in pediatric patients. Somatostatin, a peptide which stimulates serotonin release and inhibits growth hormone release, was measured in the cerebrospinal fluid (CSF) of 10 children with disruptive behavior disorders and in 10 age-, sex-, and race-matched pairs of obsessive-compulsive disorder patients. Decreased concentrations of somatostatin were found in disruptive behavior disorder patients relative to obsessive-compulsive children, even after controlling for differences in Tanner stage. In contrast to studies in adults, those patients in a depressed state did not have lower CSF somatostatin concentration.